Search Results - "Girimanchanaika, Swamy S"

Design and Activity of Novel Oxadiazole Based Compounds That Target Poly(ADP-ribose) Polymerase by Vishwanath, Divakar, Girimanchanaika, Swamy S, Dukanya, Dukanya, Rangappa, Shobith, Yang, Ji-Rui, Pandey, Vijay, Lobie, Peter E, Basappa, Basappa

“…Novel PARP inhibitors with selective mode-of-action have been approved for clinical use. Herein, oxadiazole based ligands that are predicted to target PARP-1…”
Get full text

Oxazine drug-seed induces paraptosis and apoptosis through reactive oxygen species/JNK pathway in human breast cancer cells by Kim, Na Young, Dukanya, Dukanya, Sethi, Gautam, Girimanchanaika, Swamy S, Yang, Jirui, Nagaraja, Omantheswara, Swamynayaka, Ananda, Vishwanath, Divakar, Venkantesha, Keerthikumara, Basappa, Shreeja, Chinnathambi, Arunachalam, Alharbi, Sulaiman Ali, Madegowda, Mahendra, Sukhorukov, Alexey, Pandey, Vijay, Lobie, Peter E., Basappa, Basappa, Ahn, Kwang Seok

“…•To overcome drug-resistant breast cancer, it is essential to develop compounds that induce apoptosis and paraptosis.•BSO-07 triggered G1 phase arrest, cleaved…”
Get full text

Novel 1,3,4-oxadiazole Targets STAT3 Signaling to Induce Antitumor Effect in Lung Cancer by Malojirao, Vikas H, Girimanchanaika, Swamy S, Shanmugam, Muthu K, Sherapura, Ankith, Dukanya, Metri, Prashant K, Vigneshwaran, Vellingiri, Chinnathambi, Arunachalam, Alharbi, Sulaiman Ali, Rangappa, Shobith, Mohan, Chakrabhavi Dhananjaya, Basappa, Prabhakar, Bettadathunga T, Rangappa, Kanchugarakoppal S

“…Lung cancer is the leading type of malignancy in terms of occurrence and mortality in the global context. STAT3 is an oncogenic transcription factor that is…”
Get full text